EKF Diagnostics (LON:EKF – Get Free Report) posted its quarterly earnings results on Tuesday. The company reported GBX 0.54 EPS for the quarter, Digital Look Earnings reports. EKF Diagnostics had a net margin of 4.12% and a return on equity of 3.01%.
EKF Diagnostics Price Performance
EKF stock opened at GBX 25.60 on Tuesday. EKF Diagnostics has a twelve month low of GBX 22 and a twelve month high of GBX 31.70. The business has a 50 day simple moving average of GBX 25.44 and a 200-day simple moving average of GBX 25.51. The company has a current ratio of 4.16, a quick ratio of 1.77 and a debt-to-equity ratio of 2.01. The company has a market capitalization of £109.61 million, a P/E ratio of 54.47 and a beta of 0.50.
About EKF Diagnostics
● Point-of-Care analysers in the key areas of Hematology and Diabetes
● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.
EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.
Read More
- Five stocks we like better than EKF Diagnostics
- Clearance to Climb: Why Allegiant Has Room to Fly
- 3 Defense Stocks Riding the High-Energy Laser Boom
- Analysts Are Punting Their Calls Into the Next Quarter After Adobe’s Mixed Earnings
- Institutional Money Is Pouring Into These 2 Altcoin ETFs
Receive News & Ratings for EKF Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EKF Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
